How to buy NRx Pharmaceuticals (NRXP) shares in the UK

Learn how to easily invest in NRx Pharmaceuticals shares.

NRx Pharmaceuticals Inc (NRXP) is a leading biotechnology business based in the US. On 14 September NRx Pharmaceuticals shares leapt 15.12% to a closing position of $12.64. Over the last 12 months, NRx Pharmaceuticals's share price has risen by 42.51% from $10.68. NRx Pharmaceuticals is listed on the NASDAQ. All prices are listed in US Dollars.

How to buy shares in NRx Pharmaceuticals

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: NRXP in this case.
  5. Research NRx Pharmaceuticals shares. The platform should provide the latest information available.
  6. Buy your NRx Pharmaceuticals shares. It's that simple.
The whole process can take as little as 15 minutes.

How has coronavirus impacted NRx Pharmaceuticals's share price?

Since the stock market crash that started in February 2020, NRx Pharmaceuticals's share price has had significant negative movement.

Its last market close was $10.5, which is 1.26% down on its pre-crash value of $10.634 and 7.14% up on the lowest point reached during the March 2020 crash when the shares fell as low as $9.8.

If you had bought $1,000 worth of NRx Pharmaceuticals shares at the start of February 2020, those shares would have been worth $1,002.86 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $982.28.

NRx Pharmaceuticals share price (NASDAQ:NRXP)

Use our graph to track the performance of NRXP stocks over time.

NRx Pharmaceuticals shares at a glance

Information last updated 2021-08-13.
Open$15.4041
High$15.85
Low$14.86
Close$15.22
Previous close$15.41
Change$-0.19
Change %-1.233%
Volume964,490
Information last updated 2021-09-10.
52-week range$8.39 - $64.2
50-day moving average$15.0849
200-day moving average$23.1024
Dividend yieldN/A (0%)
Earnings per share (TTM)$-26.143
Promoted
eToro Free Stocks

Invest in NRx Pharmaceuticals shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes
Capital at risk

Fees for buying 100x NRx Pharmaceuticals shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Freetrade logo £0 No minimum £4.99
£1,112.85 total
Capital at risk
eToro Free Stocks logo £0 $50 £5.54
£1,113.40 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.83
£1,109.69 total
Capital at risk
Stake logo £0 £50 £5.83
£1,113.69 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £23.32
£1,131.18 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £24.90
£1,132.76 total
Capital at risk
Fineco logo £0 No minimum £11.08
£1,118.94 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £23.64
£1,131.50 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy NRx Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

NRx Pharmaceuticals price performance over time

Historical closes compared with the last close of $15.22

1 week (2021-09-10) 26.31%
1 month (2021-08-17) 22.05%
3 months (2021-06-17) -3.55%
6 months (2021-03-17) -50.49%
1 year (2020-09-17) 42.51%
2 years (2019-09-17) 44.95%
3 years (2018-09-17) 52.20%

Financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM -9033.42%
Profit margin 0%
Book value $0.54
Market capitalisation $618.5 million

TTM: trailing 12 months

How to short and sell NRx Pharmaceuticals shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "NRXP.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 2.3 million NRx Pharmaceuticals shares held short by investors – that's known as the "short interest". This figure is 119.4% up from 1.0 million last month.

There are a few different ways that this level of interest in shorting NRx Pharmaceuticals shares can be evaluated.

Short interest ratio (SIR)

NRx Pharmaceuticals's "short interest ratio" (SIR) is the quantity of NRx Pharmaceuticals shares currently shorted divided by the average quantity of NRx Pharmaceuticals shares traded daily (recently around 22.6 million). NRx Pharmaceuticals's SIR currently stands at 0.1. In other words for every 100,000 NRx Pharmaceuticals shares traded daily on the market, roughly 100 shares are currently held short.

However NRx Pharmaceuticals's short interest can also be evaluated against the total number of NRx Pharmaceuticals shares, or, against the total number of tradable NRx Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NRx Pharmaceuticals's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 NRx Pharmaceuticals shares in existence, roughly 20 shares are currently held short) or 0.0571% of the tradable shares (for every 100,000 tradable NRx Pharmaceuticals shares, roughly 57 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NRx Pharmaceuticals.

Find out more about how you can short NRx Pharmaceuticals stock.

NRx Pharmaceuticals share dividends

We're not expecting NRx Pharmaceuticals to pay a dividend over the next 12 months. Typically it's companies that have been around for longer that pay dividends (NRx Pharmaceuticals had its IPO on 4 December 2017). However, you can browse other dividend-paying shares in our guide.

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site